• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1999年至2015年这16年间韩国胃癌治疗不依从的趋势与结果

Trends and Outcomes of Non-compliance with Treatment for Gastric Cancer in Korea over the 16 years from 1999 to 2015.

作者信息

Eom Bang Wool, Jung Kyu-Won, Won Young-Joo, Kim Young-Woo

机构信息

Center for Gastric Cancer, National Cancer Center, Goyang, Korea.

Cancer Registration and Statistics Branch, National Cancer Control Institute, Goyang, Korea.

出版信息

J Gastric Cancer. 2019 Mar;19(1):92-101. doi: 10.5230/jgc.2019.19.e5. Epub 2019 Feb 20.

DOI:10.5230/jgc.2019.19.e5
PMID:30944762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6441768/
Abstract

PURPOSE

The aim of this study was to evaluate the trend of non-compliance with treatment (NCT) among gastric cancer patients in the Korean population.

MATERIALS AND METHODS

Using data from the Korea Central Cancer Registry from 1999 to 2015, patients who did not receive any treatment for gastric cancer within 4 months after diagnosis were defined as the NCT group. The annual incidence rate, distributions according to age group and stage, and 5-year relative survival of the patients exhibiting NCT were analyzed.

RESULTS

The number of NCT patients was 5,871 (30.6%) in 1999 and continuously decreased to 4,434 (15.3%) in 2015. Between 2006 and 2015, the proportions of NCT patients decreased from 72.9% to 55.0% among those 80 years old or older and from 9.2% to 5.4% among patients younger than 40 years. In patients with distant metastases, this proportion decreased from 35.5% to 32.7%, and this proportion also decreased from 17.6% to 8.2% among those with localized disease. The 5-year relative survival rates of NCT patients between 2011 and 2015 were significantly lower than those of the treated patients in each stage (60.2% vs. 99.7%, 13.8% vs. 67.1%, and 2.0% vs. 8.3% among those with localized, regional, and distant disease, respectively).

CONCLUSIONS

The proportion of NCT gastric cancer patients has decreased during the last 16 years. However, considerable numbers of elderly patients are still NCT. There must be a strategy to decrease NCT and improve the nationwide survival rate of patients with gastric cancer.

摘要

目的

本研究旨在评估韩国人群中胃癌患者的治疗不依从(NCT)趋势。

材料与方法

利用韩国中央癌症登记处1999年至2015年的数据,将诊断后4个月内未接受任何胃癌治疗的患者定义为NCT组。分析了出现NCT的患者的年发病率、按年龄组和分期的分布以及5年相对生存率。

结果

1999年NCT患者数量为5871例(30.6%),并持续下降至2015年的4434例(15.3%)。2006年至2015年期间,80岁及以上患者中NCT患者的比例从72.9%降至55.0%,40岁以下患者中这一比例从9.2%降至5.4%。在有远处转移的患者中,这一比例从35.5%降至32.7%,在局限性疾病患者中这一比例也从17.6%降至8.2%。2011年至2015年期间,各阶段NCT患者的5年相对生存率均显著低于接受治疗的患者(局限性、区域性和远处疾病患者中分别为60.2%对99.7%、13.8%对67.1%、2.0%对8.3%)。

结论

过去16年中,NCT胃癌患者的比例有所下降。然而,仍有相当数量的老年患者存在NCT情况。必须制定一项策略以降低NCT并提高全国胃癌患者的生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e303/6441768/0f3c14ac1592/jgc-19-92-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e303/6441768/e3060e6d480a/jgc-19-92-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e303/6441768/0f3c14ac1592/jgc-19-92-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e303/6441768/e3060e6d480a/jgc-19-92-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e303/6441768/0f3c14ac1592/jgc-19-92-g002.jpg

相似文献

1
Trends and Outcomes of Non-compliance with Treatment for Gastric Cancer in Korea over the 16 years from 1999 to 2015.1999年至2015年这16年间韩国胃癌治疗不依从的趋势与结果
J Gastric Cancer. 2019 Mar;19(1):92-101. doi: 10.5230/jgc.2019.19.e5. Epub 2019 Feb 20.
2
Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999-2019).韩国胃癌流行病学:基于韩国中央癌症登记数据的发病率和生存率趋势(1999 - 2019年)
J Gastric Cancer. 2022 Jul;22(3):160-168. doi: 10.5230/jgc.2022.22.e21.
3
Real-World Compliance of Surgical Treatment According to the Korean Gastric Cancer Guideline 2018: Evaluation From the Nationwide Survey Data 2019 in Korea.依据《2018年韩国胃癌诊疗指南》的外科治疗真实世界依从性:基于2019年韩国全国性调查数据的评估
J Gastric Cancer. 2023 Oct;23(4):535-548. doi: 10.5230/jgc.2023.23.e32.
4
Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.韩国食管癌发病率和生存率的趋势:韩国中央癌症登记数据库分析。
J Gastroenterol Hepatol. 2018 Dec;33(12):1961-1968. doi: 10.1111/jgh.14289. Epub 2018 Jun 12.
5
Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.年龄增长预示着宫颈癌预后不良,进而影响治疗和总体生存。
Brachytherapy. 2019 Jan-Feb;18(1):29-37. doi: 10.1016/j.brachy.2018.08.016. Epub 2018 Oct 22.
6
Trend analysis of major cancer statistics according to sex and severity levels in Korea.韩国按性别和严重程度划分的主要癌症统计数据趋势分析。
PLoS One. 2018 Sep 13;13(9):e0203110. doi: 10.1371/journal.pone.0203110. eCollection 2018.
7
Data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry.来自韩国中央癌症登记处的韩国结直肠癌患者的特征和生存数据。
Ann Coloproctol. 2013 Aug;29(4):144-9. doi: 10.3393/ac.2013.29.4.144. Epub 2013 Aug 29.
8
Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.新辅助化疗能否提高 T3-4N1 期鼻咽癌患者的生存率?一项倾向评分匹配分析。
Radiat Oncol. 2020 Jul 2;15(1):160. doi: 10.1186/s13014-020-01594-4.
9
Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.局部晚期食管癌的新辅助治疗应针对肿瘤组织学。
Ann Thorac Surg. 2019 Jan;107(1):187-193. doi: 10.1016/j.athoracsur.2018.07.089. Epub 2018 Sep 29.
10
The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.新辅助化疗在鼻咽癌治疗中的作用:一项使用倾向评分匹配分析的多机构回顾性研究(KROG 11-06)
Cancer Res Treat. 2016 Jul;48(3):917-27. doi: 10.4143/crt.2015.265. Epub 2015 Dec 28.

引用本文的文献

1
Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.晚期食管癌或胃癌患者放弃全身治疗的考量:一项真实世界证据研究。
Int J Cancer. 2025 May 15;156(10):1950-1960. doi: 10.1002/ijc.35314. Epub 2025 Jan 9.
2
Role of Adjuvant Radiotherapy in Gastric Cancer.辅助放疗在胃癌中的作用。
J Gastric Cancer. 2023 Jan;23(1):194-206. doi: 10.5230/jgc.2023.23.e1.
3
Increasing disparities in the proportions of active treatment and 5-year overall survival over time by age groups among older patients with gastric cancer in Korea.

本文引用的文献

1
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.韩国癌症统计数据:2015 年发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2018 Apr;50(2):303-316. doi: 10.4143/crt.2018.143. Epub 2018 Mar 21.
2
Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.马来西亚公立医院乳腺癌患者使用补充和替代医学(CAM)情况以及就诊和诊断延迟情况
PLoS One. 2017 Apr 27;12(4):e0176394. doi: 10.1371/journal.pone.0176394. eCollection 2017.
3
Natural History of Early Gastric Cancer: a Case Report and Literature Review.
韩国老年胃癌患者的积极治疗比例和 5 年总生存率随年龄组的时间差异不断增大。
Front Public Health. 2023 Jan 9;10:1030565. doi: 10.3389/fpubh.2022.1030565. eCollection 2022.
4
Correlation analysis of gastric mucosal lesions with infection and its virulence genotype in Guiyang, Guizhou province, China.中国贵州省贵阳市胃黏膜病变与感染及其毒力基因型的相关性分析
Ann Transl Med. 2022 Dec;10(24):1320. doi: 10.21037/atm-22-5553.
5
Clinicopathologic Characteristics of Young Gastric Cancer Patients: Diagnostic Staging Accuracy and Survival.青年胃癌患者的临床病理特征:诊断分期准确性与生存率
J Minim Invasive Surg. 2020 Dec 15;23(4):163-171. doi: 10.7602/jmis.2020.23.4.163.
6
First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017.2006 年至 2017 年韩国外分泌胰腺肿瘤的治疗方案和预后
Cancer Res Treat. 2022 Jan;54(1):208-217. doi: 10.4143/crt.2021.421. Epub 2021 May 21.
早期胃癌的自然史:一例病例报告及文献综述
J Gastric Cancer. 2017 Mar;17(1):88-92. doi: 10.5230/jgc.2017.17.e9. Epub 2017 Mar 10.
4
Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble.35个工业化国家的未来预期寿命:基于贝叶斯模型集成的预测
Lancet. 2017 Apr 1;389(10076):1323-1335. doi: 10.1016/S0140-6736(16)32381-9. Epub 2017 Feb 22.
5
Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.韩国国家癌症筛查计划在降低胃癌死亡率方面的效果。
Gastroenterology. 2017 May;152(6):1319-1328.e7. doi: 10.1053/j.gastro.2017.01.029. Epub 2017 Jan 29.
6
Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis.晚期非小细胞肺癌患者未接受治疗的比例上升:一项倾向匹配分析
J Thorac Oncol. 2017 Mar;12(3):437-445. doi: 10.1016/j.jtho.2016.11.2221. Epub 2017 Jan 18.
7
Factors involved in the delay of treatment initiation for cervical cancer patients: A nationwide population-based study.宫颈癌患者治疗起始延迟的相关因素:一项基于全国人群的研究。
Medicine (Baltimore). 2016 Aug;95(33):e4568. doi: 10.1097/MD.0000000000004568.
8
Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.未经治疗的肝细胞癌在美国队列中的自然史及癌症监测的作用。
Clin Gastroenterol Hepatol. 2017 Feb;15(2):273-281.e1. doi: 10.1016/j.cgh.2016.07.033. Epub 2016 Aug 10.
9
Short- and Long-Term Outcomes After Gastrectomy in Elderly Gastric Cancer Patients.老年胃癌患者胃切除术后的短期和长期结局
Ann Surg Oncol. 2017 Feb;24(2):469-477. doi: 10.1245/s10434-016-5482-y. Epub 2016 Aug 3.
10
The Natural History of Operable Non-Small Cell Lung Cancer in the National Cancer Database.国家癌症数据库中可手术非小细胞肺癌的自然史
Ann Thorac Surg. 2016 May;101(5):1850-5. doi: 10.1016/j.athoracsur.2016.01.077. Epub 2016 Apr 1.